FEB 06, 2020 9:53 AM PST

Concussion detector could pick up concussions in athletes, right from the sidelines

WRITTEN BY: Tara Fernandez

Concussions are brain traumas caused by a blow to the head or a whiplash injury. The risk of concussions is greatly heightened in athletes playing high contact sports. Studies estimate that sports-related concussions occur between 1.6 and 3.8 million times per year in the United States alone.

 

 

Despite these staggering statistics, concussions remain poorly defined and are an ongoing challenge to accurately diagnose. Typically, imaging tests such as computed tomography (CT) scans are not able to pick up the subtle signs of brain injury following impact: mild bruising or brain bleeds. Instead, emergency room physicians rely largely on highly subjective functional impairments triggered by concussions, like issues with speech, memory loss, and difficulty with balance and coordination. 

Doctors and engineers at the University of Michigan have invented a portable device (pictured below) that could change this. Using pulses of infrared lasers, the device detects the early signs of concussion on a cellular level. This completely noninvasive method works simply by placing the device on an individual’s forehead.

 

 

Infrared pulses penetrate deep into the cranium and interact with cytochrome C oxidase, a metabolic enzyme that can provide diagnostic clues as to how efficiently brain cells are using oxygen. During the early phases of concussion, levels of cytochrome C oxidase plunge, allowing the early identification of individuals requiring immediate medical attention. 

As Steven Broglio, director of the Michigan Concussion Center said, “The quicker you identify a concussion, the faster you can begin the recovery process of resting and gradually returning to normal activity. Research in the last 10 years has shown that resting sooner can shorten recovery time, helping people get back to school, work and military duty.”

 

Sources: University of Michigan News.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JAN 15, 2020
Clinical & Molecular DX
Laser microchip picks up cancer markers in urine
JAN 15, 2020
Laser microchip picks up cancer markers in urine
A future where patients no longer need to endure expensive, painful and complicated cancer tests could soon become a rea ...
JAN 13, 2020
Chemistry & Physics
Magnetic Field-guided Tethered-probe Can Navigate Complex Vascular Networks
JAN 13, 2020
Magnetic Field-guided Tethered-probe Can Navigate Complex Vascular Networks
Deep and complex vasculatures such as carotid arteries represent a challenge for diagnosis and treatment because they ar ...
APR 14, 2020
Clinical & Molecular DX
Urchin-shaped DNA Biosensor Detects Disease Earlier
APR 14, 2020
Urchin-shaped DNA Biosensor Detects Disease Earlier
For researchers at the Missouri University of Science and Technology developing a new class of nanodiagnostics, good thi ...
APR 29, 2020
Clinical & Molecular DX
Move and Detect : Diagnosis of Neonatal Sepsis Using Fluorescent Micromotors
APR 29, 2020
Move and Detect : Diagnosis of Neonatal Sepsis Using Fluorescent Micromotors
According to the World Health Organization (WHO), sepsis occurs when the body’s response to an infection injures i ...
JUN 04, 2020
Clinical & Molecular DX
Low T Cells Linked To High COVID Risk
JUN 04, 2020
Low T Cells Linked To High COVID Risk
  German scientists have found a link between immune cell counts and the risk of developing severe, potentially lif ...
JUN 26, 2020
Cardiology
Drug for Osteoporosis Linked to Increased Risk of Adverse Cardiovascular Events
JUN 26, 2020
Drug for Osteoporosis Linked to Increased Risk of Adverse Cardiovascular Events
In a recent study done by Jonas Bovijn, MBChB, MSc, DLSHTM, of the Big Data Institute at the University of Oxford’ ...
Loading Comments...